e-learning
resources
Monograph
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular side-effects of common antibiotics
Francesco Amati, Marta Di Pasquale, Marcos I. Restrepo, Judith Marin-Corral, Stefano Aliberti, Francesco Blasi
Source:
Eur Respir Monogr 2020; 88: 264-278
Journal Issue:
Cardiovascular Complications of Respiratory Disorders
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Francesco Amati, Marta Di Pasquale, Marcos I. Restrepo, Judith Marin-Corral, Stefano Aliberti, Francesco Blasi. Cardiovascular side-effects of common antibiotics. Eur Respir Monogr 2020; 88: 264-278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Cardiovascular adverse effects during itraconazole therapy
Source: Eur Respir J 2008; 32: 240
Year: 2008
Cardiovascular complications and comorbidities in CAP
Source: Eur Respir Monogr 2014; 63: 256-254
Year: 2014
Cardiovascular events related to the use of varenicline
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012
Cardiovascular diseases and COVID-19
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021
Severe adverse effects of antitubercular drugs and patient management
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Cardiovascular complications of mild OSA
Source: ERS Conference
Year: 2015
Cardiovascular complications of mild OSA
Source: International Congress 2017 – Sleep and Breathing
Year: 2017
Cardiovascular complications in mild OSA
Source: Sleep and Breathing Conference 2017
Year: 2017
Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Cardiovascular complications and norfenfluramine exposure with benfluorex use
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Active monitoring of adverse drug reactions to the use of beta-lactam antibiotics in the treatment of community-acquired pneumonia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Cardiovascular patients
Source: Eur Respir Monogr 2021; 90: 208-228
Year: 2021
Antibiotics therapy against airway’s infections during pregnancy and related problems
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Respiratory adverse effects in oncology nurses exposed to antineplastic drugs
Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies
Year: 2015
Adverse effects of anti-tuberculosis drugs in hemodialysis patients
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Adverse anti-tuberculosis drug events and their management
Source: Eur Respir Monogr 2018; 82: 205-227
Year: 2018
Management of adverse drug events in TB therapy
Source: Eur Respir Mon 2012; 58: 167-193
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept